Charles Schwab Investment Management Inc Tyra Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 173,737 shares of TYRA stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,737
Previous 169,945
2.23%
Holding current value
$2.43 Million
Previous $2.72 Million
50.31%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$146 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$90.3 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$65.3 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$61.7 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$56.8 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $588M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...